Clincosm LogoSign in Get a demo

telogen effluvium

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Telogen Effluvium Trial (BL 3000, Reference Pantogar, BL3000 Placebo)

Not yet recruiting
  • Telogen Effluvium
  • BL 3000
  • +3 more
  • (no location specified)
Jul 5, 2022

PAI-1 Expression in Non-scarring Hair Loss

Terminated
  • Androgenetic Alopecia
  • +2 more
    • Chicago, Illinois
      Northwestern University Department of Dermatology
    Jun 7, 2022

    COVID-19 Induced Telogen Effluvium

    Recruiting
    • Covid19
    • +3 more
    • Blood Tests
    • Istanbul, Kadıköy, Turkey
      Istanbul Medeniyet University
    Apr 4, 2021

    Telogen Effluvium Trial in Paris (RV3466F lotion, Shampoo)

    Completed
    • Telogen Effluvium
    • RV3466F lotion
    • Shampoo
    • Paris, France
    • +1 more
    Nov 26, 2020

    Androgenetic Alopecia, Androgenic Alopecia, Telogen Effluvium Trial in San Francisco (ALRV5XR, ALRV5XR Shampoo, ALRV5XR

    Completed
    • Androgenetic Alopecia
    • +5 more
    • ALRV5XR
    • +7 more
    • San Francisco, California
      Biometrix
    Jun 26, 2020

    Androgenetic Alopecia, Androgenic Alopecia, Telogen Effluvium Trial in San Francisco (ALRV5XR, ALRV5XR Shampoo, ALRV5XR

    Completed
    • Androgenetic Alopecia
    • +5 more
    • ALRV5XR
    • +7 more
    • San Francisco, California
      Biometrix
    Jun 26, 2020

    Telogen Effluvium Trial in Toulouse (Hair follicles sampling)

    Completed
    • Telogen Effluvium
    • Hair follicles sampling
    • Toulouse, France
      Hôpital Purpan
    May 14, 2020

    Telogen Effluvium Trial (Bioscalin® new formulation with Galeopsis Segetum, Reference product, Placebo)

    Completed
    • Telogen Effluvium
    • Bioscalin® new formulation with Galeopsis Segetum
    • +2 more
    • (no location specified)
    Sep 1, 2017